Healthcare
Graphite purchases Sovereign’s City & County
Graphite Capital has acquired home care provider City & County Healthcare Group from Sovereign Capital.
Gimv backs Eurocept
Gimv has invested in Eurocept Group, a Dutch provider of medical homecare services and specialised medicines, in exchange for a minority stake.
Duke Street backs Air Products homecare carve-out
Duke Street has backed the management buyout of NYSE-listed Air Products & Chemicals' UK homecare business.
PE still in race for Rexam healthcare unit
Medical supply maker Gerresheimer has dropped out of the bidding process for Rexam's healthcare unit, while private equity firms such as Bain and KKR are still in the race, according to local reports.
Vækstfonden backs Nanovi with €600,000
Vækstfonden has provided €600,000 in seed capital for Nanovi, a Danish company developing products based on biomaterials for the treatment of cancer.
Telormedix raises $6.6m from Aravis and Proquest
Swiss biopharmaceutical company Telormedix has raised $6.6m in a series-B financing round extension from existing backers Aravis Venture and Proquest Investments.
Deal in focus: MIG backs Ganymed in €45m series-E
MIG Verwaltungs has reinvested in biopharmaceutical company Ganymed Pharmaceuticals in a joint €45m series-E financing round, alongside family office ATS Beteiligungsverwaltung, in what marks the largest biotechnology early-stage investment in the DACH...
Gimv, UI Gestion acquire Almaviva
Gimv and UI Gestion have acquired French operator of private clinics Almaviva Santé from 21 Partners, with each of the firms contributing €40m towards the buyout.
CEA Investissement et al. back Bioaxial
Paris-based medical equipment company Bioaxial has raised €1.9m from CEA Investissement, Viveris Management, Inserm Transfert Initiative (ITI) and several individual investors.
Novartis to offload assets
Swiss pharmaceutical giant Novartis has announced it is open to spinning out non-core assets as part of its strategic review and its plans for a $5bn share buy-back.
Gilde Healthcare closes fund on €145m
Gilde Healthcare Partners has held the final close of its transatlantic life sciences venture fund, Gilde Healthcare III (GHC III), on its target of €145m.
VC-backed Implanet floats
French medical technology company Implanet, backed by several venture capital firms, has listed on the NYSE Euronext Paris with a market cap of €39m.
Pulmocide secures £17m in series-A
UK-based inhaled medicines developer Pulmocide has raised £17m in its series-A financing round from a consortium of investors led by Imperial Innovations.
Sofinnova leads €15m round for Pixium
Sofinnova Partners has led a €15m extension of Pixium Vision’s two-part series-A round alongside BPI France and existing investors Omnes Capital and Abingworth Management.
VC-backed Oxford Immunotec raises $64m in IPO
UK-based medical diagnostics company Oxford Immunotec Global, which is backed by a consortium of investors, has listed on the Nasdaq with a market cap of $196.3m.
GE Capital and Ares refinance Astorg's Ethypharm
GE Capital and Ares Management have provided Astorg Partners portfolio company Ethypharm with a €170m unitranche facility.
JLL Partners, Royal DSM create $2.6bn pharma business
US private equity house JLL Partners and Dutch life sciences group Royal DSM have teamed up and combined assets to create a new, independent pharmaceutical company in a deal worth $2.6bn.
Sofinnova Partners et al. sell EOS for up to €310m
Sofinnova Partners, Aescap Venture and Principia have sold Milan-based cancer therapeutics firm Ethical Oncology Science (EOS) to Clovis Oncology via an agreement that could see the firm fetch up to €310m.
Auriga holds €40m first close for Bioseeds fund
French VC Auriga Partners has held a first close on €40m for its latest vehicle, Auriga IV Bioseeds, after seven months on the road.
IBB and HTGF back Scopis in series-A
IBB Beteiligungsgesellschaft and High-Tech Gründerfonds (HTGF) have supported Scopis in a series-A financing round.
Ganymed Pharmaceuticals raises €45m in series-E
Biopharmaceutical company Ganymed Pharmaceuticals has raised €45m in a series-E financing round from MIG and family office ATS Beteiligungsverwaltung.
Mission Therapeutics raises £20m
A syndicate of new and existing venture capital investors has injected £20m into UK-based biotech Mission Therapeutics as part of its series-B funding round.
Argos Soditic buys Cisbio Bioassays
Argos Soditic has backed the €25m management buyout of French biotech company Cisbio Bioassays.
August buys The Old Deanery Care Village
August Equity has acquired Essex-based care home business The Old Deanery Care Village.